Peripheral Oxygen Saturation as a Digital Biomarker

SpO2 estimates the percentage of haemoglobin carrying oxygen. It is a well established clinical measurement and a considerably weaker one when taken from the wrist.

Status
Validated
Unit
%
Data type
Percentage
Sensor
Reflectance pulse oximetry
Worn
Wrist

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Established
Analytical validation
Emerging
Clinical validation
Established

Clinical pulse oximetry is an established and cleared measurement with decades of use. Wrist based reflectance estimation is substantially less accurate, is affected by skin pigmentation in a documented and persistent way, and is generally offered as a wellness feature.

What is Peripheral Oxygen Saturation

Peripheral oxygen saturation is the proportion of haemoglobin in arterial blood that is bound to oxygen, estimated non invasively from how tissue absorbs light at different wavelengths. Written SpO2 to distinguish it from SaO2 measured directly in blood, it is one of the most widely used measurements in medicine and one of the few vital signs a consumer device attempts to reproduce.

The distinction between the clinical measurement and the wearable estimate matters more here than almost anywhere else in this library. Fingertip transmission pulse oximetry passes light through tissue and is a cleared medical measurement. Wrist devices use reflectance, reading light scattered back from tissue with far less signal to work with, and most position their output as a wellness feature rather than a clinical measurement. Both report a percentage, and that shared unit conceals a substantial difference in reliability.

How it is measured

Clinical pulse oximeters shine red and infrared light through a fingertip or earlobe and compare absorption across the pulsatile component of the signal. Wrist worn devices place emitters and detectors on the same surface and measure backscatter, typically sampling during sleep when the wearer is still, because motion degrades the estimate severely.

Accuracy depends on perfusion, motion, device fit and skin pigmentation. The pigmentation effect is documented rather than theoretical: pulse oximetry overestimates saturation more often in patients with darker skin, meaning hypoxaemia can be missed in exactly the group already facing worse outcomes, and analysis has shown this bias has not improved over three decades of device development. Studies collecting SpO2 should record skin tone and treat the measurement as having population dependent error.

Clinical use

In respiratory research SpO2 is used to characterise disease severity, to detect exacerbation and desaturation, and as a safety parameter. In sleep research, overnight desaturation measures sit alongside the apnoea hypopnoea index and describe the physiological consequence of breathing interruption. In trials unrelated to the lungs, it is frequently collected simply as a safety signal.

Nocturnal SpO2 from wearables has the strongest case, because the wearer is still, the recording spans many hours, and the question is usually about pattern rather than absolute value. Daytime spot readings from a wrist device carry much less information. Across uses, the measure is reported alongside a breathlessness instrument such as the mMRC scale or the Borg CR10, since saturation and the sensation of breathlessness diverge frequently.

Regulatory status

Fingertip pulse oximeters are regulated medical devices. Most wrist worn SpO2 features are positioned as wellness functions rather than cleared measurements, and that distinction should be checked per device rather than assumed.

Limitations

Wrist based estimation is less accurate than fingertip oximetry, which is itself less accurate than arterial blood gas analysis. Motion, poor perfusion, cold extremities and loose fit all degrade the reading, and skin pigmentation introduces a systematic bias that has persisted across device generations.

Most consumer implementations are positioned as wellness features and are not cleared medical measurements, so clinical decisions should not rest on them. Saturation is also a late signal in deterioration: it can remain normal while a person is working hard to breathe, which is why it should be interpreted alongside breathing rate and symptoms rather than on its own.

References

Related instruments

No questionnaire measures oxygen saturation directly. It is listed alongside breathlessness scales such as the mMRC and the Borg CR10 because saturation and the sensation of breathlessness are related but diverge often enough that both are usually reported.

Use case
Monitoring · Safety
Collect Peripheral Oxygen Saturation and other digital biomarkers in one workflow. Or turn your research into a new digital biomarker?
Capture wearable physiology alongside breathlessness and symptom instruments in a single study workflow.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.